NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $213,000 | -13.4% | 2,247 | -16.7% | 0.03% | -19.4% |
| Q2 2019 | $246,000 | -18.5% | 2,696 | -14.3% | 0.04% | -18.2% |
| Q1 2019 | $302,000 | +11.9% | 3,146 | 0.0% | 0.04% | -4.3% |
| Q4 2018 | $270,000 | -7.8% | 3,146 | -7.4% | 0.05% | +9.5% |
| Q3 2018 | $293,000 | -0.3% | 3,396 | -12.8% | 0.04% | -4.5% |
| Q2 2018 | $294,000 | -32.6% | 3,896 | -27.8% | 0.04% | -34.3% |
| Q1 2018 | $436,000 | -8.8% | 5,396 | -5.3% | 0.07% | -9.5% |
| Q4 2017 | $478,000 | -2.2% | 5,696 | 0.0% | 0.07% | -8.6% |
| Q3 2017 | $489,000 | +37.0% | 5,696 | -1.5% | 0.08% | +19.1% |
| Q2 2017 | $357,000 | -1.7% | 5,781 | +18.2% | 0.07% | -4.2% |
| Q1 2017 | $363,000 | -7.9% | 4,890 | -9.6% | 0.07% | -13.4% |
| Q4 2016 | $394,000 | – | 5,410 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |